---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-023183"
form_type: "8-K"
ticker: "VICP"
cik: "0001468639"
company_name: "Vicapsys Life Sciences, Inc."
filed_at: "2023-06-30T23:59:59+00:00"
generated_at: "2026-06-13T13:52:53.090610+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Vicapsys Life Sciences issues $330K note to AJB Capital, 10% interest, 8% OID, due Dec 2023

## Summary
- Principal $330,000, purchase price $303,600 (8% OID), 10% annual interest, maturity December 27, 2023.
- Issued 328,571 unregistered commitment fee shares to AJB Capital as part of the agreement.
- Default triggers 150% acceleration, 18% interest, and conversion at average of 3 lowest VWAP prices.
- Proceeds from the note will be used for general working capital purposes.
- Note is convertible into common stock upon an event of default at a formula-based conversion price.

## SEC filing metadata
- accession: 0001493152-23-023183
- form_type: 8-K
- ticker: VICP
- cik: 0001468639
- company_name: Vicapsys Life Sciences, Inc.
- filed_at: 2023-06-30T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468639/000149315223023183/0001493152-23-023183-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468639/000149315223023183/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-023183
- JSON: https://secwatch.observer/filing/0001493152-23-023183.json
- Plain text: https://secwatch.observer/filing/0001493152-23-023183.txt

## Key facts
- Debt Financings
  Vicapsys Life Sciences, Inc. incurred loan of $330,000 with AJB Capital Investments, LLC at 10% a year maturing December 27, 2023.
  - Instrument: loan
  - Principal: $330,000
  - Counterparty: AJB Capital Investments, LLC
  - Rate: 10% a year
  - Maturity: December 27, 2023
  - Event: incurrence
  source text: On June 27, 2023, we entered into a securities purchase agreement (the “SPA”) with AJB Capital Investments, LLC (“AJB”) and issued a promissory note in the principal amount of $330,000 (the “note”) to AJB pursuant to the SPA for an purchase price of $303,600.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468639/000149315223023183/0001493152-23-023183-index.htm
- Material Agreements
  Vicapsys Life Sciences, Inc. entered into SPA with AJB Capital Investments, LLC valued at principal amount of $330,000 (effective 2023-06-27).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: AJB Capital Investments, LLC
  - Value: principal amount of $330,000
  - Effective: 2023-06-27
  source text: On June 27, 2023, we entered into a securities purchase agreement (the "SPA") with AJB Capital Investments, LLC ("AJB") and issued a promissory note in the principal amount of $330,000 (the "note") to AJB pursuant to the SPA for an purchase price of $303,600.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468639/000149315223023183/0001493152-23-023183-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.